SANEXAS RST NeoGEN Neuropathy

$8.500

SANEXAS RST NeoGEN Neuropathy Pain Treatment System The Synaptic NeoGEN System is an advanced electrical cell signaling technology (EST) device designed for the treatment of neuropathy and chronic pain. Utilizing cutting-edge bio-electrical stimulation, the NeoGEN system promotes natural nerve cell communication and helps restore normal nerve function, offering patients a non-invasive, drug-free alternative to pain management.…

Category:
Tags:

Description

SANEXAS RST NeoGEN Neuropathy Pain Treatment System

The Synaptic NeoGEN System is an advanced electrical cell signaling technology (EST) device designed for the treatment of neuropathy and chronic pain. Utilizing cutting-edge bio-electrical stimulation, the NeoGEN system promotes natural nerve cell communication and helps restore normal nerve function, offering patients a non-invasive, drug-free alternative to pain management.

Developed by Rebuilder Services Technologies (RST-SANEXAS), this system delivers multiple therapeutic frequencies to stimulate deep cellular repair and improve microcirculation — addressing the root cause of neuropathic pain rather than masking symptoms. The result is a safe, comfortable, and highly effective therapy for patients suffering from diabetic neuropathy, chronic pain, and nerve disorders.

Key Features:

  • âš¡ Electrical Cell Signaling Therapy (EST) – Uses patented waveforms to restore nerve cell communication and function.

  • Multi-Frequency Stimulation – Targets deep and superficial tissues for comprehensive pain relief.

  • Non-Invasive & Drug-Free – Provides safe therapy without medications, injections, or surgery.

  • Patient-Friendly Design – Delivers gentle electrical pulses for comfortable, relaxing treatments.

  • Clinically Proven Results – Shown to reduce pain, tingling, and numbness associated with peripheral neuropathy.

  • Versatile Clinical Use – Ideal for pain management, physical therapy, and neurology practices.

Applications:

  • Peripheral neuropathy (diabetic, idiopathic, chemotherapy-induced)

  • Chronic pain and nerve damage

  • Circulatory and neuromuscular disorders

  • Painful sensory neuropathy

  • Post-surgical and injury-related nerve pain

Technical Highlights:

  • Technology: Electrical Cell Signaling (EST)

  • Frequency range: Variable, multi-waveform output

  • Output channels: Dual or multi-site therapy capability

  • Interface: Digital touchscreen with pre-set treatment protocols

  • Safety: FDA-cleared, non-invasive medical device

Why Choose the NeoGEN System:

The NeoGEN Electrical Cell Signaling System represents the future of neuropathy and chronic pain therapy. By treating the underlying cause of nerve dysfunction through advanced bio-electrical stimulation, it empowers clinicians to deliver long-lasting pain relief and functional improvement — safely and effectively.